These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7982714)

  • 1. [Laboratory diagnosis of parvovirus B 19 infection: comparison of ten commercial IgG- and IgM-antibody tests].
    Helftenbein E; Kunz H; Hartter P
    Immun Infekt; 1994 Oct; 22(5):181-6. PubMed ID: 7982714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
    Pfrepper KI; Enders M; Motz M
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant immunoblot and ELISA for detection of acute parvovirus B19 infection.
    Schwarz TF; Jäger G
    Zentralbl Bakteriol; 1994 Mar; 280(4):526-33. PubMed ID: 8061414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection.
    Chen MY; Lee KL; Hung CC
    J Formos Med Assoc; 2000 Jan; 99(1):24-32. PubMed ID: 10743343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant human parvovirus B19 antigens in serological assays.
    Cubie HA; Leslie EE; Smith S; O'Neill HJ; Hart H; Cohen BJ; Inglis JM
    J Clin Pathol; 1993 Sep; 46(9):840-5. PubMed ID: 8227436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
    Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
    J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection.
    Pereira RF; Paula WN; Cubel Rde C; Nascimento JP
    Mem Inst Oswaldo Cruz; 2001 May; 96(4):507-13. PubMed ID: 11391423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women.
    Jordan JA
    J Clin Microbiol; 2000 Apr; 38(4):1472-5. PubMed ID: 10747128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Responsiveness of a new parvovirus B19 antigen produced in baculovirus expression system to B19-specific IgG and IgM antibodies in every epidemic, 1968, 1980, 1987 and 1992 in Japan].
    Nunoue T
    Kansenshogaku Zasshi; 1995 May; 69(5):546-52. PubMed ID: 7602188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
    Işik N; Ağaçfidan A; Ağirbaşli H; Işik DM; Bozkaya E; Gedikoğlu G; Badur S
    Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection.
    Enders M; Helbig S; Hunjet A; Pfister H; Reichhuber C; Motz M
    J Virol Methods; 2007 Dec; 146(1-2):409-13. PubMed ID: 17854916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops.
    Enders M; Weidner A; Rosenthal T; Baisch C; Hedman L; Söderlund-Venermo M; Hedman K
    J Infect Dis; 2008 Jan; 197(1):58-62. PubMed ID: 18171285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sero-diagnosis for human parvovirus B19 infection by IgM and IgG antibody capture method of enzyme-linked immunosorbent assay--study on an epidemic case of erythema infectiosum].
    Matsunaga Y; Yamazaki S; Moritsugu Y; Kuwabara Y; Nishigaki M
    Kansenshogaku Zasshi; 1992 Apr; 66(4):434-40. PubMed ID: 1624835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
    Kerr S; O'Keeffe G; Kilty C; Doyle S
    J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
    J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parvovirus B19 infection: the general aspects and gestational problems].
    Di Stefano L; Carta G; Barnabei R; Tomei E; Toro G; Moscarini M
    Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary and secondary infection with human parvovirus B19 in pregnant women in South Africa.
    Schoub BD; Blackburn NK; Johnson S; McAnerney JM
    S Afr Med J; 1993 Jul; 83(7):505-6. PubMed ID: 8211491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 4 commercial test kits for parvovirus B19-specific IgM.
    Cohen BJ; Bates CM
    J Virol Methods; 1995 Sep; 55(1):11-25. PubMed ID: 8576300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of human parvovirus B19 DNA using PCR and serological test using ELISA for diagnosis of infection].
    Saito Y; Ikegaya K; Yano S; Yamauchi T; Hikiji K
    Rinsho Byori; 1993 Feb; 41(2):203-8. PubMed ID: 8361022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19.
    Bruu AL; Nordbø SA
    J Clin Microbiol; 1995 May; 33(5):1363-5. PubMed ID: 7615755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.